Lantheus Holdings (NASDAQ:LNTH) has agreed to sell its Puerto Rico-based radiopharmacy and positron emission tomography manufacturing facility to PharmaLogic Holdings Corp. PharmaLogic will pay $18 million to acquire the assets. The two companies also agreed to enter into a long-term supply agreement in which Lantheus will supply PharmaLogic with a range of products. The transaction…